IGF1 and Hyperinsulinemia: Insulin resistance is associated with hyperinsulinemia and insulin-like growth factor-1 (IGF-1) levels, which activate downstream insulin receptor substrates and key oncogenic signaling cascades, including the PI3K/AKT/mTOR and MAPK/ERK pathways [88].